NICE backs radionuclide therapy for some neuroendocrine tumours

20th July 2018 Uncategorised 0

A price cut has secured NHS funding for Advanced Accelerator Applications’ Lutathera as a treatment for some neuroendocrine tumours (NETs).

More: NICE backs radionuclide therapy for some neuroendocrine tumours
Source: News